Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cue Health (HLTH)
NASDAQ:HLTH
Cue Health (HLTH) Stock Price & Analysis
214 Followers
HLTH Stock Chart & Stats
Day’s Range$0.04 - $0.06
52-Week Range― - ―
Previous Close$0.06
Volume96.00M
Average Volume (3M)N/A
Market Cap
$795.46K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next Earnings
Aug 07, 2024EPS Estimate
-$0.19Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$1.00Price Target Upside2204.15% Upside
Rating ConsensusHold
Number of Analyst Covering2
Cue Health News
PremiumCompany Announcements
Cue Health Reduces Net Loss Despite Revenue Decline
PremiumCompany Announcements
Cue Health Navigates Board Changes and Regulatory Challenges
PremiumCompany Announcements
Cue Health Announces CFO Transition and New AppointmentPremiumCompany Announcements
Cue Health Finalizes Separation Terms with Ex-Officer KhattakBulls Say, Bears Say
Bulls Say
Cost SavingsHL TH delivered $200M in annualized run rate cost savings for 2023, surpassing its $150M goal.
Earnings4Q revenue of $18.8M was above expectations and the previous guidance range, driven by strong pull-through from the Cue Reader installed base and ongoing Cue Integrated Care platform adoption.
LeadershipThe appointment of Dr. Paul Brown, the former CEO of Roche Molecular Diagnostics, as a strategic advisor could provide valuable insight and experience.
Bears Say
Financial PerformanceThe company's cash runway is estimated at approximately three quarters, which is concerning given the challenging capital markets.
Regulatory ApprovalFDA's denial of Cue's Flu A/B + COVID-19 molecular test EUA approval due to significant issues identified.
Workforce ReductionCue Health's workforce reduction by about 60% could impede the company's ability to meet its pipeline timelines.
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
28.49% Other Institutional Investors
71.51% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
HLTH FAQ
What was Cue Health’s price range in the past 12 months?
Currently, no data Available
What is Cue Health’s market cap?
Currently, no data Available
When is Cue Health’s upcoming earnings report date?
Cue Health’s upcoming earnings report date is Aug 07, 2024 which is in 34 days.
How were Cue Health’s earnings last quarter?
Cue Health released its earnings results on May 13, 2024. The company reported -$0.312 earnings per share for the quarter, beating the consensus estimate of -$0.377 by $0.065.
Is Cue Health overvalued?
According to Wall Street analysts Cue Health’s price is currently Undervalued.
Does Cue Health pay dividends?
Cue Health does not currently pay dividends.
What is Cue Health’s EPS estimate?
Cue Health’s EPS estimate is -$0.19.
How many shares outstanding does Cue Health have?
Currently, no data Available
What happened to Cue Health’s price movement after its last earnings report?
Cue Health reported an EPS of -$0.312 in its last earnings report, beating expectations of -$0.377. Following the earnings report the stock price went down -7.692%.
Which hedge fund is a major shareholder of Cue Health?
Among the largest hedge funds holding Cue Health’s share is Perceptive Advisors LLC. It holds Cue Health’s shares valued at N/A.
---
Cue Health Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$1.00 (2204.15% Upside)
$1.00 (2204.15% Upside)
Blogger Sentiment
Bullish
HLTH Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 2.3M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.6%
Last 30 Days ▲ 9.7%
Last 30 Days ▲ 9.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Fundamentals
Return on Equity
-94.57%
Trailing 12-Months
Asset Growth
-53.39%
Trailing 12-Months
Company Description
Cue Health
Cue Health Inc is a health technology company. It puts consumers in control of health information and places diagnostic information at the center of care. It enables people to manage health through real-time, actionable and connected health data. Further, it offers individuals, enterprises, government agencies and healthcare providers access to lab-quality diagnostic testing at home, at work, or at the point-of-care, all in a device that fits in the palm of hand.
---
HLTH Earnings Call
Q4 2024
0:00 / 0:00
---
HLTH Stock 12 Month Forecast
Average Price Target
$1.00
▲(2204.15% Upside)
Technical Analysis
---